M4MM

Aurora and Curaleaf Trade Statements in Ongoing Bid Dispute

EDMONTON - STAMFORD – Aurora Cannabis and Curaleaf Holdings continued their public exchange over Curaleaf’s unsolicited takeover offer for the Canadian medical Cannabis company. Aurora issued a statement responding to Curaleaf’s regulatory filing, while Curaleaf ...

Definium Achieves Second Positive Phase 3 for GAD

NEW YORK – Definium Therapeutics Inc. released topline data from its second pivotal Phase 3 trial (Panorama study) of DT120 in generalized anxiety disorder (GAD), adding to earlier positive findings in the same indication and ...

High Tide Reports Q3 2026 Financial Results

CALGARY – High Tide Inc. posted revenue of $198.8 million for the three months ended July 31, 2026, a 33% increase from the same period last year and the fifth consecutive quarterly record. Gross profit ...

Aurora and Curaleaf Trade Statements in Ongoing Bid Dispute

EDMONTON - STAMFORD – Aurora Cannabis and Curaleaf Holdings continued their public exchange over Curaleaf’s unsolicited takeover offer for the Canadian medical Cannabis company. Aurora issued a statement responding to Curaleaf’s regulatory filing, while Curaleaf ...

Definium Achieves Second Positive Phase 3 for GAD

NEW YORK – Definium Therapeutics Inc. released topline data from its second pivotal Phase 3 trial (Panorama study) of DT120 in generalized anxiety disorder (GAD), adding to earlier positive findings in the same indication and ...

High Tide Reports Q3 2026 Financial Results

CALGARY – High Tide Inc. posted revenue of $198.8 million for the three months ended July 31, 2026, a 33% increase from the same period last year and the fifth consecutive quarterly record. Gross profit ...

Aurora and Curaleaf Trade Statements in Ongoing Bid Dispute

EDMONTON - STAMFORD – Aurora Cannabis and Curaleaf Holdings continued their public exchange over Curaleaf’s unsolicited takeover offer for the Canadian medical Cannabis company. Aurora issued a statement responding to Curaleaf’s regulatory filing, while Curaleaf ...

Definium Achieves Second Positive Phase 3 for GAD

NEW YORK – Definium Therapeutics Inc. released topline data from its second pivotal Phase 3 trial (Panorama study) of DT120 in generalized anxiety disorder (GAD), adding to earlier positive findings in the same indication and ...

High Tide Reports Q3 2026 Financial Results

CALGARY – High Tide Inc. posted revenue of $198.8 million for the three months ended July 31, 2026, a 33% increase from the same period last year and the fifth consecutive quarterly record. Gross profit ...

Aurora and Curaleaf Trade Statements in Ongoing Bid Dispute

EDMONTON - STAMFORD – Aurora Cannabis and Curaleaf Holdings continued their public exchange over Curaleaf’s unsolicited takeover offer for the Canadian medical Cannabis company. Aurora issued a statement responding to Curaleaf’s regulatory filing, while Curaleaf ...

Definium Achieves Second Positive Phase 3 for GAD

NEW YORK – Definium Therapeutics Inc. released topline data from its second pivotal Phase 3 trial (Panorama study) of DT120 in generalized anxiety disorder (GAD), adding to earlier positive findings in the same indication and ...

High Tide Reports Q3 2026 Financial Results

CALGARY – High Tide Inc. posted revenue of $198.8 million for the three months ended July 31, 2026, a 33% increase from the same period last year and the fifth consecutive quarterly record. Gross profit ...

Cannara Secures Upgraded $80M Credit Line

MONTREAL – Cannara Biotech Inc. announced that its operating subsidiary has entered into an amended and restated syndicated credit agreement with Bank of Montreal (BMO) and The Toronto-Dominion Bank (TD), establishing $80 million in committed ...

Virginia Unveils Draft Rules for Adult-Use Cannabis Market

RICHMOND – The Virginia Cannabis Control Authority (CCA) released an 80-plus-page draft regulatory framework for the state's forthcoming adult-use market – the first detailed set of proposed rules since the General Assembly authorized commercial sales ...

Eli Lilly Completes Acquisition of AtaiBeckley

INDIANAPOLIS – Eli Lilly & Co. has closed its acquisition of AtaiBeckley Inc., the New York-based biopharmaceutical company developing psychedelic-derived therapies for treatment-resistant mental health conditions. The transaction cleared its final U.S. regulatory checkpoint when ...

Cannaflex Opens European Export Route

RABAT – Moroccan operator Cannaflex has secured EU-GMP compliance verification for the commercial export of medical Cannabis starting materials to Switzerland and broader European markets, marking an operational milestone for the Kingdom's legal framework. Working ...

Grown Rogue Launches Cultivation Ops in Minnesota

MEDFORD – Grown Rogue International Inc. officially began cultivation operations at its Fridley, Minnesota facility, nine months after first securing the location in December 2025. Phase I puts roughly 8,000 sq. feet of flowering canopy ...

Elixinol Offloads Its US Hemp Business to Ananda Health

SYDNEY – Australian Elixinol Wellness Limited has entered into a binding asset purchase agreement with Ananda Health to sell its wholly-owned subsidiary, Elixinol LLC, effectively exiting the United States hemp market. Under the transaction terms, ...

Subscribe To Our Newsletter